scholarly journals The Use of Molecular Breast Imaging to Assess Response in Women Undergoing Neoadjuvant Therapy for Breast Cancer

2012 ◽  
Vol 37 (4) ◽  
pp. 344-350 ◽  
Author(s):  
Dietlind L. Wahner-Roedler ◽  
Judy C. Boughey ◽  
Carrie B. Hruska ◽  
Beiyun Chen ◽  
Deborah J. Rhodes ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Neoadjuvant Therapy ◽  
Breast Imaging ◽  
Molecular Breast Imaging

Molecular Breast Imaging: A Scientific Review

2021 ◽  
Author(s):  
Katie N Hunt
Keyword(s):  
Breast Cancer ◽  
Breast Imaging ◽  
Breast Mri ◽  
Cancer Staging ◽  
Scientific Review ◽  
Molecular Breast Imaging ◽  
Breast Cancer Staging ◽  
Fast Learning ◽  
Technical Advances ◽  
History Of

Abstract Molecular breast imaging (MBI) is a nuclear medicine technique that has evolved considerably over the past two decades. Technical advances have allowed reductions in administered doses to the point that they are now acceptable for screening. The most common radiotracer used in MBI, 99mTc-sestamibi, has a long history of safe use. Biopsy capability has become available in recent years, with early clinical experience demonstrating technically successful biopsies of MBI-detected lesions. MBI has been shown to be an effective supplemental screening tool in women with dense breasts and is also utilized for breast cancer staging, assessment of response to neoadjuvant chemotherapy, problem solving, and as an alternative to breast MRI in women who have a contraindication to MRI. The degree of background parenchymal uptake on MBI shows promise as a tool for breast cancer risk stratification. Radiologist interpretation is guided by a validated MBI lexicon that mirrors the BI-RADS lexicon. With short interpretation times, a fast learning curve for radiologists, and a substantially lower cost than breast MRI, MBI provides many benefits in the practices in which it is utilized. This review will discuss the current state of MBI technology, clinical applications of MBI, MBI interpretation, radiation dose associated with MBI, and the future of MBI.

scholarly journals The clinical impact of molecular breast imaging in women with proven invasive breast cancer scheduled for breast-conserving surgery

2018 ◽  
Vol 169 (3) ◽  
pp. 513-522 ◽  
Author(s):  
Angela Collarino ◽  
Renato A. Valdés Olmos ◽  
Lotta G. A. J. van Berkel ◽  
Peter A. Neijenhuis ◽  
Lidy M. H. Wijers ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Invasive Breast Cancer ◽  
Breast Imaging ◽  
Breast Conserving Surgery ◽  
Clinical Impact ◽  
Molecular Breast Imaging

scholarly journals Background Parenchymal Uptake on Molecular Breast Imaging and Breast Cancer Risk: A Cohort Study

2020 ◽  
Author(s):  
Carrie Beth Hruska ◽  
Jennifer R. Geske ◽  
Amy Lynn Conners ◽  
Dana H. Whaley ◽  
Deborah J. Rhodes ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cohort Study ◽  
Breast Cancer Risk ◽  
Cancer Risk ◽  
Breast Imaging ◽  
Molecular Breast Imaging

scholarly journals Quantitative background parenchymal uptake on molecular breast imaging and breast cancer risk: a case-control study

2018 ◽  
Vol 20 (1) ◽  
Author(s):  
Carrie B. Hruska ◽  
Jennifer R. Geske ◽  
Tiffinee N. Swanson ◽  
Alyssa N. Mammel ◽  
David S. Lake ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Breast Cancer Risk ◽  
Cancer Risk ◽  
Breast Imaging ◽  
Case Control Study ◽  
Case Control ◽  
Molecular Breast Imaging ◽  
Control Study

Supplemental Breast Cancer Screening With Molecular Breast Imaging for Women With Dense Breast Tissue

2016 ◽  
Vol 207 (2) ◽  
pp. 450-457 ◽  
Author(s):  
Robin B. Shermis ◽  
Keith D. Wilson ◽  
Malcolm T. Doyle ◽  
Tamara S. Martin ◽  
Dawn Merryman ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Screening ◽  
Breast Cancer Screening ◽  
Breast Imaging ◽  
Breast Tissue ◽  
Dense Breast ◽  
Molecular Breast Imaging ◽  
Dense Breast Tissue
Sign in / Sign up

Export Citation Format

Share Document